Nine Masts Capital »

Apellis Pharmaceuticals shares owned by Nine Masts Capital

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Nine Masts Capital from 13F filings

Historical chart of Nine Masts Capital investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Nine Masts Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Nine Masts Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.9M 98k 40.23

More positions owned by Nine Masts Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Alphabet Cap Stk Cl C (GOOG)
Warner Bros Discovery Com Ser A (WBD)
Silicon Laboratories (SLAB)
Hdfc Bank Sponsored Ads (HDB)
Electronic Arts (EA)
Fox Corp Cl B Com (FOX)
Norfolk Southern (NSC)
Clearwater Analytics Hldgs I Cl A (CWAN)
Webster Financial Corporation (WBS)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Hologic
Nio Note 4.625%10/1 (Principal)
Ase Technology Hldg Sponsored Ads (ASX)

View all positions for Nine Masts Capital

Top funds holding Apellis Pharmaceuticals

BlackRock
Wellington Management Company
venBio Select Advisor
Vanguard Group
Morgan Stanley
Rtw Investments
UBS Group
Vanguard Portfolio Management
Pentwater Capital Management
Vanguard Capital Management
State Street Corporation
Deep Track Capital
Point72 Asset Management
Polar Capital Holdings
HBK Investments

View all funds holding Apellis Pharmaceuticals